BIWA 4
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BIWA 4, covering 2014-07-30 to 2014-07-30. Get the full timeline:
Most recent: Clinical Trial Update: Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Adenocarcinoma of the Breast [Phase 1]